T2DM is also characterized by impaired insulin secretion due to β-cell loss [59,60], an additional dire effect of the enhanced secretion of pro-inflammatory cytokines (IL-6, TNF-α, and IL-1β) [61,62,63,64]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.